4//SEC Filing
MUTO FREDERICK T 4
Accession 0000874015-21-000085
CIK 0000874015other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:05 PM ET
Size
19.0 KB
Accession
0000874015-21-000085
Insider Transaction Report
Form 4
MUTO FREDERICK T
Director
Transactions
- Exercise/Conversion
Common Stock
2021-06-15$9.30/sh+5,000$46,500→ 36,683 total - Sale
Common Stock
2021-06-15$36.55/sh−5,000$182,750→ 31,683 total - Sale
Common Stock
2021-06-15$36.85/sh−5,000$184,250→ 31,683 total - Sale
Common Stock
2021-06-15$36.50/sh−5,000$182,500→ 31,683 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-06-15−5,000→ 10,000 totalExercise: $9.30From: 2012-07-01Exp: 2021-06-30→ Common Stock (5,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-06-15−5,000→ 5,000 totalExercise: $9.30From: 2012-07-01Exp: 2021-06-30→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-06-15$9.30/sh+5,000$46,500→ 36,683 total - Exercise/Conversion
Common Stock
2021-06-15$9.30/sh+5,000$46,500→ 36,683 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-06-15−5,000→ 0 totalExercise: $9.30From: 2012-07-01Exp: 2021-06-30→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Acquired as a result of exercising a stock option that was scheduled to expire on June 30, 2021. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.
- [F2]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001181560
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:05 PM ET
- Size
- 19.0 KB